Arginine Taurine Cosmetic Composition for Non-Invasive Skin Lifting
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cosmetic solutions fail to provide an immediate and lasting 'lifting' effect that effectively reduces wrinkle visibility and enhances skin tone and suppleness, similar to the results achieved by intradermic injections of botulinum toxin, while being safe and non-toxic.
Innovation Solution
A cosmetic composition combining arginine and taurine in specific concentrations, formulated into various chemical-physical forms such as monophasic gels, oil-in-water emulsions, and monophasic solutions, which are non-cytotoxic and non-phototoxic, and possess antioxidant properties to improve skin elasticity and aesthetic appeal.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If intradermic injections of botulinum toxin are used to achieve a lifting effect, then wrinkle visibility is reduced and skin tone is enhanced, but the method is invasive and carries cytotoxic risks
Solution Approach 1:
The patent changes the chemical parameters by using specific concentrations of arginine (0.1-5% w/w) and taurine (0.1-5% w/w) to achieve a lifting effect without cytotoxicity. This parameter optimization allows the composition to mimic botulinum toxin effects while maintaining safety
Solution Approach 2:
The patent combines arginine and taurine in a specific formulation to create a composite cosmetic composition that produces synergistic effects. This combination achieves the desired lifting effect while eliminating the harmful properties of botulinum toxin injections
2Speed
If cosmetic compositions are designed to provide immediate lifting effects, then wrinkle visibility is reduced within hours, but the effect duration is limited
Solution Approach 1:
The patent employs periodic reapplication of the cosmetic composition to maintain the lifting effect. While each application provides immediate results lasting several hours, repeated applications sustain the aesthetic benefit over longer periods
Solution Approach 2:
The patent optimizes the concentration parameters of arginine and taurine to maximize both the speed of effect onset and the duration of action, achieving the fastest possible lifting effect within the constraints of topical application safety
3Strength
If high concentrations of active ingredients are used to enhance lifting effect, then skin tension and elasticity improve, but cytotoxicity risk increases
Solution Approach 1:
The patent carefully optimizes the concentration parameters of arginine (0.1-5% w/w) and taurine (0.1-5% w/w) to achieve maximum skin elasticity and tension improvement while remaining below cytotoxic thresholds. This parameter optimization resolves the contradiction between effect strength and safety
Solution Approach 2:
The patent uses safe, non-cytotoxic concentrations of arginine and taurine that require periodic reapplication rather than high concentrations that would cause toxicity. This approach prioritizes long-term safety over intensive single-use effects
Data Source
AI summary
This invention concerns a cosmetic composition for topical use containing as an active principle a blend of arginine and taurine designed to carry out an immediate "lifting" effect and able to improve in a short time the aesthetic characteristics of the cutis. The composition contains a quantity in weight of arginine of 0, 05% p/p at 90% p/p, preferably from 0, 5% p/p to 5% p/p, and a quantity in weight of taurine from 0, 05% p/p to 90% p/p, preferably from 0, 5% p/p to 5% p/p.